February 07, 2025

Hematologic Indicators Linked to Alopecia Areata Severity

Researchers analyze hematological ratios in alopecia areata severity assessment.

Conexiant

February 07, 2025

24-Month Study Shows Ritlecitinib Efficacy in Alopecia

73.5% of patients achieved a SALT score ≤ 20 after 24 months of ritlecitinib treatment, according to new phase III findings.

Conexiant

February 07, 2025

First Merkel Cell Cancer Institute Opens

UW Medicine launches collaborative research center to combat rare skin cancer

Conexiant

February 05, 2025

Predictive Rituximab Protocol Reduces Pemphigus Relapse Risk

French multicenter study demonstrates targeted rituximab maintenance therapy guided by clinical and serological markers cuts early pemphigus relapse rates from 17.6% to 2.6%

Conexiant

February 05, 2025

Enlarging Painless Nodule Destroying Nail: What's Your Diagnosis?

A painless finger nodule leads to nail destruction, revealing an uncommon but locally aggressive tumor of the tendon sheath.

Conexiant

February 05, 2025

New Study Explores COVID-19’s Dermatologic Impact

More than 20% of COVID-19 patients experience skin conditions, ranging from rashes to pseudochilblains, linked to immune response.

Conexiant

February 03, 2025

Key Comorbidities Elevate Risk of Severe Alopecia Areata

Study finds bronchial asthma, dermatitis, and thyroiditis significantly increase risk for early-onset, severe, and prolonged alopecia areata.

Conexiant

February 01, 2025

Resin Composite Restorations: Innovations and Technology Continue to Drive Success

Contemporary dentistry cannot be performed without resin-based restorative materials, light-curing units, and sectional matrix band systems.

Compendium

January 30, 2025

Study Links Psoriasis to Elevated Sjögren’s Risk

The results highlight the need for clinicians to monitor psoriasis patients, especially those with PsA, for early signs of Sjögren’s syndrome.

Conexiant